Post by CeMM

🚀 𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝗼𝘂𝗿 𝗹𝗮𝘁𝗲𝘀𝘁 #𝗙𝗿𝗼𝗻𝘁𝗥𝗼𝘄𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗽𝗼𝘀𝘁 𝘄𝗶𝘁𝗵 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗼𝘂𝗿 #𝗖𝗲𝗠𝗠𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵𝗥𝗲𝗽𝗼𝗿𝘁𝟮𝟬𝟮𝟱! Discover the CeMM facilities featured today: 🧫 The 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺 (𝗠𝗗𝗣) combines proteomics, metabolomics, and chemical screening technologies to discover and characterize bioactive molecules. In 2025, the platform implemented new proteomics workflows, upgraded metabolomics analysis workflows, and made full use of its recently upgraded chemical screening infrastructure, now providing access to more than 100,000 compounds and new “direct-to-biology” approaches for faster discovery. 👉 https://bit.ly/4x6sawY 📸 Team discussion at Das MuTh (Klaus Pichler / CeMM) 🧬 As Austria’s first technology platform dedicated to next-generation sequencing (NGS) in biomedicine, the 𝗕𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗦𝗲𝗾𝘂𝗲𝗻𝗰𝗶𝗻𝗴 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝘆 (𝗕𝗦𝗙) provides researchers with access to NGS expertise and supports projects from study design to sample preparation, sequencing, and bioinformatics analysis. The team further expanded its single-cell portfolio, particularly for fixed cells, and adopted the latest GEM-X assays that generate data from twice as many cells as the previous generation, enabling more robust detection of rare cell populations. 👉 https://bit.ly/4dM4tCH 📸 Team discussion at the Vestibül of the Burgtheater (Klaus Pichler / CeMM) #TechPlatforms #NextGenSeq #Proteomics #Metabolomics #ChemicalBiology #ScienceIsOurMedicine